The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
122315153 12231515 3 F 201503 20160804 20160401 20160810 EXP US-JNJFOC-20160318784 JANSSEN 41.02 YR A F Y 0.00000 20160810 CN US US

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
122315153 12231515 1 SS XARELTO RIVAROXABAN 1 Oral Y N UNKNOWN;UNKNOWN;UNKNOWN;UNKNOWN 0 20 MG TABLET
122315153 12231515 2 SS XARELTO RIVAROXABAN 1 Oral Y N UNKNOWN;UNKNOWN;UNKNOWN;UNKNOWN 0 15 MG TABLET
122315153 12231515 3 SS XARELTO RIVAROXABAN 1 Oral DOSE VARYING FROM 15MG TO 20 MG. Y N UNKNOWN;UNKNOWN;UNKNOWN;UNKNOWN 0 20 MG TABLET
122315153 12231515 4 SS XARELTO RIVAROXABAN 1 Oral DOSE VARYING FROM 15MG TO 20 MG. Y N UNKNOWN;UNKNOWN;UNKNOWN;UNKNOWN 0 20 MG TABLET
122315153 12231515 5 SS XARELTO RIVAROXABAN 1 Oral Y N UNKNOWN;UNKNOWN;UNKNOWN;UNKNOWN 0 15 MG TABLET
122315153 12231515 6 PS XARELTO RIVAROXABAN 1 Oral Y N UNKNOWN;UNKNOWN;UNKNOWN;UNKNOWN 22406 20 MG TABLET
122315153 12231515 7 SS IBUPROFEN. IBUPROFEN 1 Unknown Y N 19012 UNSPECIFIED
122315153 12231515 8 SS IBUPROFEN. IBUPROFEN 1 Unknown Y N 19012 UNSPECIFIED
122315153 12231515 9 C TAMOXIFEN TAMOXIFEN 1 Unknown 0 UNSPECIFIED
122315153 12231515 10 C ANASTROZOLE. ANASTROZOLE 1 Unknown 0 UNSPECIFIED
122315153 12231515 11 C NORCO ACETAMINOPHENHYDROCODONE BITARTRATE 1 Unknown 0 UNSPECIFIED

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
122315153 12231515 1 Thrombosis prophylaxis
122315153 12231515 2 Thrombosis prophylaxis
122315153 12231515 3 Thrombosis prophylaxis
122315153 12231515 4 Thrombosis prophylaxis
122315153 12231515 5 Thrombosis prophylaxis
122315153 12231515 6 Thrombosis prophylaxis
122315153 12231515 7 Abdominal pain
122315153 12231515 8 Back pain
122315153 12231515 9 Product used for unknown indication
122315153 12231515 10 Product used for unknown indication
122315153 12231515 11 Product used for unknown indication

Outcome of event

Event ID CASEID OUTC COD
122315153 12231515 HO
122315153 12231515 OT

Reactions reported

Event ID CASEID DRUG REC ACT PT
122315153 12231515 Gastrointestinal haemorrhage
122315153 12231515 Pulmonary embolism
122315153 12231515 Rectal haemorrhage

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

Event ID CASEID DSG DRUG SEQ START DT END DT DUR DUR COD
122315153 12231515 1 20150530 20150830 0
122315153 12231515 2 20150324 20150413 0
122315153 12231515 3 20150324 20150504 0
122315153 12231515 4 20150324 20150504 0
122315153 12231515 5 20150324 20150413 0
122315153 12231515 6 20150530 20150830 0
122315153 12231515 7 20120426 0
122315153 12231515 8 20120426 0
122315153 12231515 9 20130110 20150323 0